News

BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...
The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...
The Translational Research Grant (TRG) program funds projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions. The ...
This practical, one-hour virtual session is designed to help North Carolina life sciences companies understand the basic steps of obtaining CE Mark certification. Regulatory experts from North ...
Cambrex Corp., a contract manufacturer of small-molecule therapeutics with a growing facility in High Point, has signed an agreement to acquire Avista Pharma Solutions, a contract development, ...
Raleigh-based UVision360 has achieved a dual-indication 510(k) clearance from the U.S. Food and Drug Administration for its all-in-one gynecological system LUMINELLE DTx Hysteroscopy System. The dual ...
Pappas Capital, a Durham-based investor in early-stage life sciences companies, has appointed Karen LeVert as venture partner. She will help expand the firm’s Specialized Fund Management business – ...
Over the past year my colleague Nandini Mendu, Ph.D., senior director, agriculture sector development, has been working on a strategic project looking into North Carolina’s animal health and nutrition ...
Working as a physician assistant (PA) in vascular surgery at Duke University Medical Center for over 13 years, Shawn Gage has treated thousands of patients with a variety of vascular diseases and ...
Worried that your dog might contract the COVID-19 coronavirus – and what pet owner isn’t these days? Or concerned that your meandering daily dog walks could result in close encounters of the human ...